Author:
Vissink A.,Spijkervet F. K. L.,Bootsma H.,Kallenberg C. G. M.
Reference48 articles.
1. Asmussen K, Andersen V, Bendixen G, Schiødt M, Oxholm P. A new model for classification of disease manifestations in primary Sjögren’s syndrome: evaluation in a retrospective long-term study. J Intern Med 1996;239(6):475–82.
2. Asmussen KH, Bowman SJ. Outcome measures in Sjögren’s syndrome. Rheumatology (Oxford) 2001;40(10):1085–8.
3. Atkinson JC, Travis WD, Pillemer SR, Bermudez D, Wolff A, Fox PC. Major salivary gland function in primary Sjögren’s syndrome and its relationship to clinical features. J Rheumatol 1990;17(3):318–22.
4. Backman S, Berra A, Sterin-Borda L, Borda E. Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome. Invest Ophthalmol Vis Sci 2001;42(2):321–7.
5. Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM. Hematologic manifestations and predictors of lymphoma development in primary Sjögren’s syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) 2009;88(5):284–93.